Cargando…

Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction

Background: The incidence of acute myocardial infarction (AMI) in the younger population has been increasing gradually in recent years. The objective of the present study is to investigate the safety and effectiveness of drug-eluting balloons (DEBs) in young patients with AMI. Methods: All consecuti...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yi-Xing, He, Kui-Zheng, Li, Jiang-Yuan, Fu, Yuan, Li, Chuang, Liu, Xin-Ming, Wang, Hong-Jiang, Chen, Mu-Lei, Su, Pi-Xiong, Xu, Li, Wang, Le-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865202/
https://www.ncbi.nlm.nih.gov/pubmed/36661924
http://dx.doi.org/10.3390/jcdd10010029
_version_ 1784875777965162496
author Yang, Yi-Xing
He, Kui-Zheng
Li, Jiang-Yuan
Fu, Yuan
Li, Chuang
Liu, Xin-Ming
Wang, Hong-Jiang
Chen, Mu-Lei
Su, Pi-Xiong
Xu, Li
Wang, Le-Feng
author_facet Yang, Yi-Xing
He, Kui-Zheng
Li, Jiang-Yuan
Fu, Yuan
Li, Chuang
Liu, Xin-Ming
Wang, Hong-Jiang
Chen, Mu-Lei
Su, Pi-Xiong
Xu, Li
Wang, Le-Feng
author_sort Yang, Yi-Xing
collection PubMed
description Background: The incidence of acute myocardial infarction (AMI) in the younger population has been increasing gradually in recent years. The objective of the present study is to investigate the safety and effectiveness of drug-eluting balloons (DEBs) in young patients with AMI. Methods: All consecutive patients with AMI aged ≤ 45 years were retrospectively enrolled. The primary endpoint was a device-oriented composite endpoint (DOCE) of cardiac death, target vessel myocardial infarction (MI), or target lesion revascularization (TLR). The secondary study endpoints included heart failure and major bleeding events. Results: A total of 276 young patients presenting with AMI were finally included. The median follow-up period was 1155 days. Patients treated with DEBs had a trend toward a lower incidence of DOCEs (3.0% vs. 11.0%, p = 0.12) mainly driven by the need for TLR (3.0% vs. 9.1%, p = 0.19) than those treated with DESs. No significant differences between the two groups were detected in the occurrence of cardiac death (0.0% vs. 0.5%, p = 0.69), MI (0.0% vs. 1.4%, p = 0.40), heart failure (0.0% vs. 1.9%, p = 0.39), or major bleeding events (1.5% vs 4.8%, p = 0.30). Multivariate regression analysis showed that DEBs were associated with a trend toward a lower risk of DOCEs (HR 0.13, 95% CI [0.02, 1.05], p = 0.06). Conclusions: The findings of the present study suggested that DEBs might be a potential treatment option in young patients with AMI. A larger scale, randomized, multicenter study is required to investigate the safety and effectiveness of DEBs in this setting.
format Online
Article
Text
id pubmed-9865202
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98652022023-01-22 Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction Yang, Yi-Xing He, Kui-Zheng Li, Jiang-Yuan Fu, Yuan Li, Chuang Liu, Xin-Ming Wang, Hong-Jiang Chen, Mu-Lei Su, Pi-Xiong Xu, Li Wang, Le-Feng J Cardiovasc Dev Dis Article Background: The incidence of acute myocardial infarction (AMI) in the younger population has been increasing gradually in recent years. The objective of the present study is to investigate the safety and effectiveness of drug-eluting balloons (DEBs) in young patients with AMI. Methods: All consecutive patients with AMI aged ≤ 45 years were retrospectively enrolled. The primary endpoint was a device-oriented composite endpoint (DOCE) of cardiac death, target vessel myocardial infarction (MI), or target lesion revascularization (TLR). The secondary study endpoints included heart failure and major bleeding events. Results: A total of 276 young patients presenting with AMI were finally included. The median follow-up period was 1155 days. Patients treated with DEBs had a trend toward a lower incidence of DOCEs (3.0% vs. 11.0%, p = 0.12) mainly driven by the need for TLR (3.0% vs. 9.1%, p = 0.19) than those treated with DESs. No significant differences between the two groups were detected in the occurrence of cardiac death (0.0% vs. 0.5%, p = 0.69), MI (0.0% vs. 1.4%, p = 0.40), heart failure (0.0% vs. 1.9%, p = 0.39), or major bleeding events (1.5% vs 4.8%, p = 0.30). Multivariate regression analysis showed that DEBs were associated with a trend toward a lower risk of DOCEs (HR 0.13, 95% CI [0.02, 1.05], p = 0.06). Conclusions: The findings of the present study suggested that DEBs might be a potential treatment option in young patients with AMI. A larger scale, randomized, multicenter study is required to investigate the safety and effectiveness of DEBs in this setting. MDPI 2023-01-13 /pmc/articles/PMC9865202/ /pubmed/36661924 http://dx.doi.org/10.3390/jcdd10010029 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yang, Yi-Xing
He, Kui-Zheng
Li, Jiang-Yuan
Fu, Yuan
Li, Chuang
Liu, Xin-Ming
Wang, Hong-Jiang
Chen, Mu-Lei
Su, Pi-Xiong
Xu, Li
Wang, Le-Feng
Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
title Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
title_full Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
title_fullStr Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
title_full_unstemmed Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
title_short Comparisons of Drug-Eluting Balloon versus Drug-Eluting Stent in the Treatment of Young Patients with Acute Myocardial Infarction
title_sort comparisons of drug-eluting balloon versus drug-eluting stent in the treatment of young patients with acute myocardial infarction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865202/
https://www.ncbi.nlm.nih.gov/pubmed/36661924
http://dx.doi.org/10.3390/jcdd10010029
work_keys_str_mv AT yangyixing comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT hekuizheng comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT lijiangyuan comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT fuyuan comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT lichuang comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT liuxinming comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT wanghongjiang comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT chenmulei comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT supixiong comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT xuli comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction
AT wanglefeng comparisonsofdrugelutingballoonversusdrugelutingstentinthetreatmentofyoungpatientswithacutemyocardialinfarction